Patient Groups Urge U.S. District Court to Preserve Preventive Services Coverage Requirement
Washington, D.C.— Patient groups representing millions of people with serious health conditions submitted an amicus brief today urging the U.S.
Washington, D.C.— Patient groups representing millions of people with serious health conditions submitted an amicus brief today urging the U.S.
RICHMOND, VA– November 30, 2022 – A statement from Brian Donohue, Director of Government Relations at the American Cancer Society Cancer Action Network in Virginia, follows on the death of Congressional Representative to Virginia’s 4th District, Donald McEachin, from his battle with co
National nonprofit organizations including the American Cancer Society Cancer Action Network (ACS CAN), alongside colorectal cancer (CRC) advocates, celebrate as Medicare beneficiaries will no longer face out-of-pocket costs for a necessary colonoscopy after a positive noninvasive screening test.
Today U.S. District Court Judge Reed O’Connor issued a ruling that may lead Affordable Care Act-compliant health plans to deny coverage for or reinstate cost-sharing for certain preventive health services.
The Centers for Medicare and Medicaid Services (CMS) released proposed changes to the 2023 Medicare program that, if finalized, would eliminate cost sharing for colonoscopies after a positive non-invasive screening test, and lower the minimum age of colorectal cancer screening to 45.
Sen. Judith Zaffirini (SD-21) received the Advocacy in Action award recently, one of the most prestigious awards presented by the American Cancer Society Cancer Action Network (ACS CAN), in recognition of her significant contributions to the fight against cancer in Texas, including her leadership this past session in authoring legislation that makes it more affordable for Texans to receive their lifesaving colorectal cancer screenings.
AUSTIN, TX – April 14, 2022 – Rep. John Smithee and Rep.
HOUSTON, TX – April 7, 2022 – Rep.
INDIANAPOLIS, IN.
The President announced this morning he is ‘reigniting’ his commitment to ‘end cancer as we know it,’ building on the initial and robust cancer moonshot investment in discovery, prioritizing increased uptake of prevention and addressing health disparities.